“…20 Average convalescent time was reduced from 11.6 days for epicardial/abdominal implants to 4.6 days for nonthoracotomy abdominal implants and to 2.9 days for nonthoracotomy pectoral implants. Compared with the epicardial/ abdominal group, average charges were reduced by 40% in the abdominal group and by 55% in the pectoral group using the transvenous lead system.…”
Section: The Future: Icd Technology and Patient Managementmentioning
Recent literature suggests that ICDs are a cost-effective therapy for management of life-threatening ventricular tachyarrhythmias. The advent of new technology and patient management practices should further improve the cost-effectiveness of ICD therapy. Future studies of ICD cost-effectiveness should address the implications of truncated follow-up periods and quality of life.
“…20 Average convalescent time was reduced from 11.6 days for epicardial/abdominal implants to 4.6 days for nonthoracotomy abdominal implants and to 2.9 days for nonthoracotomy pectoral implants. Compared with the epicardial/ abdominal group, average charges were reduced by 40% in the abdominal group and by 55% in the pectoral group using the transvenous lead system.…”
Section: The Future: Icd Technology and Patient Managementmentioning
Recent literature suggests that ICDs are a cost-effective therapy for management of life-threatening ventricular tachyarrhythmias. The advent of new technology and patient management practices should further improve the cost-effectiveness of ICD therapy. Future studies of ICD cost-effectiveness should address the implications of truncated follow-up periods and quality of life.
“…Neben den Ergebnissen anderer Untersuchungen [3,54,57] wird diese Aussage eindrucksvoll durch die Untersuchung von Mushlin et al gestützt [67]. Die Einführung transvenöser Elektrodensysteme war ein wesentlicher Punkt der Kostenreduktion und ermöglichte in Verbindung mit der deutlichen Größenreduktion der Defibrillatorgeneratoren eine technisch einfache Implantation bei einer zusätzlichen Verkürzung der Dauer des stationären Aufenthalts der Patienten [20]. Die in den letzten Jahren realisierte Verlängerung der Lebensdauer der implantierten Systeme ist ein weiterer zentraler Punkt, der zu einer Verbesserung der Kosteneffektivität beiträgt.…”
Section: Neuzner J Et Al Sozioökonomische Aspekte Der Behandlung Vounclassified
In the current clinical cardiac electrophysiology well-defined and effective concepts regarding the diagnostic and treatment of cardiac arrhythmias have been introduced. A further improvement in the cost-benefit and the cost-effectiveness relationships in several fields of cardiac electrophysiology depends on the future technical progress and on the results of ongoing and future scientific studies. On the other side very cost-saving electrophysiological treatments had been developed; the broader clinical use of these treatments is a possibility to optimize the costs for patients' care with cardiac arrhythmias.
“…Specifically, Medtronic has never stated that the Transvene lead Models 6936/6966 “… have lower than expected longevity.” In fact, the Transvene leads, which were released in the US market in 1993, were state‐of‐the‐art at the time and were a significant improvement over the epicardial patch leads. The Transvene leads allowed more patients to be implanted due to the reduced morbidity and mortality and a significant reduction in hospital stay 2 …”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.